Metabolism of dichloromethane (methylene chloride) to formaldehyde in human erythrocytes: influence of polymorphism of glutathione transferase Theta (GST T1-1)
- 144 Downloads
Human hemolysate was incubated in vitro with different concentrations of dichloromethane (methylene chloride). The resulting enzymatically mediated production of formaldehyde was determined by two independent analytical methods (Nash-reaction/colorimetry or HPLC). The formation of formaldehyde from dichloromethane is influenced by the polymorphism of glutathione-S-transferase (GST) Theta, in the same way as the metabolism of methyl bromide, methyl chloride, methyl iodide and ethylene oxide. Three quarters of the population (“conjugators”) possess, whereas one quarter (“non-conjugators”) lack this enzyme activity in human erythrocytes. The metabolism of dichloromethane in hemolysate in vitro can be described by Michaelis-Menten kinetics; for an individual with high GST T1-1 enzyme activity, the maximum velocity of formaldehyde production was calculated to be approximately 180 pmol/min per mg Hb, the k M being approximately 60 mM dichloromethane. Carcinogenicity of dichloromethane in long-term inhalation exposure of rodents has been attributed to metabolism of the compound via the GST-dependent pathway. Extrapolation of the results to humans for risk assessment should consider the newly discovered polymorphic enzyme activity of GST Theta. Furthermore, the possible existence of a “high-risk” population among humans should be considered in epidemiological research.
Key wordsDichloromethane Methylene chloride Formaldehyde Human erythrocytes Enzyme polymorphism Glutathione-S-transferase Theta Risk assessment
Unable to display preview. Download preview PDF.
- Bolt HM (1994) Open issues in experimental developmental toxicity and carcinogenicity of dichloromethane (methylene chloride). Toxicol Environ Chem (in press)Google Scholar
- ECETOC (1987) Technical Report No. 26: the assessment of carcinogenic hazard for human beings exposed to methylene chloride. ECETOC, BrusselsGoogle Scholar
- ECETOC (1988) Technical Report No. 32: Methylene chloride (dichloromethane): human risk assessment using experimental animal data. ECETOC, BrusselsGoogle Scholar
- ECETOC (1989) Technical Report No. 34: Methylene chloride (dichloromethane): an overview of experimental work investigating species, differences in carcinogenicity and their relevance to man. ECETOC, BrusselsGoogle Scholar
- Hallier E, Langhof T, Dannappel D, Leutbecher M, Schröder K, Goergens HW, Müller A, Bolt HM (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 67: 173–178PubMedCrossRefGoogle Scholar
- IARC, International Agency for Research on Cancer (1986) Dichloromethane. IARC Monogr 41: 43–85Google Scholar
- IARC, International Agency for Research on Cancer (1987) Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1–42. IARC Monogr Suppl 7Google Scholar
- NTP, National Toxicology Program (1986) Technical report on the toxicology and carcinogenesis studies of dichloromethane in F344/N rats and B6C3F1 mice (inhalation studies). US Dept of Health and Human Services. NIH publication No. 86-2562, NTP-TR 306Google Scholar
- Pemble S, Schröder K, Taylor JB, Spencer S, Meyer DS, Hallier E, Bolt HM, Ketterer B (1993) Human glutathione transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biol Chem Hoppe-Seyler 374: 796Google Scholar
- Thier R, Pemble SM, Taylor JB, Humphreys WG, Ketterer B, Guengerich FP (1993) Glutathione S-transferase 5–5 expression in S. typhimurium increases mutation rate caused by methylene dihalides. Pharmacol Toxicol 73 [Suppl II]: 42Google Scholar
- Vangala RR, Bolt HM (1993) Investigation of DNA damage in lung and liver of male B6C3F1 mice after inhalative exposure to high levels of methylene chloride. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 347: R 23Google Scholar